Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes.

Bordin A, Trembizki E, Windsor M, Wee R, Tan LY, Buckley C, Syrmis M, Bergh H, Cottrell K, Zowawi HM, Sidjabat HE, Harris PNA, Nimmo GR, Paterson DL, Whiley DM.

BMC Infect Dis. 2019 Jul 2;19(1):571. doi: 10.1186/s12879-019-4176-z.

2.

Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history.

Hanrahan JK, Hogan TR, Buckley C, Trembizki E, Mitchell H, Lau CL, Whiley DM, Lahra MM.

J Antimicrob Chemother. 2019 Aug 1;74(8):2214-2219. doi: 10.1093/jac/dkz182.

PMID:
31170281
3.

Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.

Ebeyan S, Windsor M, Bordin A, Mhango L, Erskine S, Trembizki E, Mokany E, Tan LY, Whiley D; GRAND2 Study Investigators .

J Antimicrob Chemother. 2019 Jul 1;74(7):1820-1824. doi: 10.1093/jac/dkz108.

PMID:
30897201
4.

Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

Sweeney EL, Trembizki E, Bletchly C, Bradshaw CS, Menon A, Francis F, Langton-Lockton J, Nimmo GR, Whiley DM.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01555-18. doi: 10.1128/JCM.01555-18. Print 2019 Mar.

5.

Discovery of mcr-1-Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage.

Forde BM, Zowawi HM, Harris PNA, Roberts L, Ibrahim E, Shaikh N, Deshmukh A, Sid Ahmed MA, Al Maslamani M, Cottrell K, Trembizki E, Sundac L, Yu HH, Li J, Schembri MA, Whiley DM, Paterson DL, Beatson SA.

mSphere. 2018 Oct 10;3(5). pii: e00486-18. doi: 10.1128/mSphere.00486-18.

6.

Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.

Zowawi HM, Syrmis MW, Kidd TJ, Balkhy HH, Walsh TR, Al Johani SM, Al Jindan RY, Alfaresi M, Ibrahim E, Al-Jardani A, Al Salman J, Dashti AA, Sidjabat HE, Baz O, Trembizki E, Whiley DM, Paterson DL.

J Med Microbiol. 2018 Jun;67(6):846-853. doi: 10.1099/jmm.0.000730. Epub 2018 Apr 17.

PMID:
29664716
7.

Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia.

Buckley C, Forde BM, Trembizki E, Lahra MM, Beatson SA, Whiley DM.

Sci Rep. 2018 Jan 24;8(1):1503. doi: 10.1038/s41598-018-20015-x.

8.

High levels of macrolide-resistant Mycoplasma genitalium in Queensland, Australia.

Trembizki E, Buckley C, Bletchly C, Nimmo GR, Whiley DM.

J Med Microbiol. 2017 Oct;66(10):1451-1453. doi: 10.1099/jmm.0.000584. Epub 2017 Sep 12.

9.

Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.

Whiley DM, Trembizki E, Buckley C, Freeman K, Baird RW, Beaman M, Chen M, Donovan B, Kundu RL, Fairley CK, Guy R, Hogan T, Kaldor JM, Karimi M, Limnios A, Regan DG, Ryder N, Su JY, Ward J, Lahra MM.

Emerg Infect Dis. 2017 Sep;23(9):1478-1485. doi: 10.3201/eid2309.170427.

10.

Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains.

Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, Cole M, Seah C, Trembizki E, Trees DL, Kersh EN, Abrams AJ, de Vries HJC, van Dam AP, Medina I, Bharat A, Mulvey MR, Van Domselaar G, Martin I.

J Clin Microbiol. 2017 May;55(5):1454-1468. doi: 10.1128/JCM.00100-17. Epub 2017 Feb 22.

11.

Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia.

Lahra MM, Ward A, Trembizki E, Hermanson J, Clements E, Lawrence A, Whiley D.

Lancet Infect Dis. 2017 Feb;17(2):133-134. doi: 10.1016/S1473-3099(17)30007-5. No abstract available.

PMID:
28134103
12.

Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.

Lahra MM, Trembizki E, Buckley C, Donovan B, Chen M, Guy R, Kundu RL, Regan DG, Whiley DM; GRAND Study Investigators.

J Antimicrob Chemother. 2017 Mar 1;72(3):705-711. doi: 10.1093/jac/dkw452.

PMID:
27999043
13.

Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?

Goire N, Kundu R, Trembizki E, Buckley C, Hogan TR, Lewis DA, Branley JM, Whiley DM, Lahra MM.

J Antimicrob Chemother. 2017 Feb;72(2):407-409. doi: 10.1093/jac/dkw406. Epub 2016 Oct 5.

PMID:
27707989
14.

Further evidence to support the individualised treatment of gonorrhoea with ciprofloxacin.

Trembizki E, Guy R, Donovan B, Kaldor JM, Lahra MM, Whiley DM; GRAND study investigators.

Lancet Infect Dis. 2016 Sep;16(9):1005-1006. doi: 10.1016/S1473-3099(16)30271-7. No abstract available.

PMID:
27684341
15.

The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012.

Trembizki E, Wand H, Donovan B, Chen M, Fairley CK, Freeman K, Guy R, Kaldor JM, Lahra MM, Lawrence A, Lau C, Pearson J, Regan DG, Ryder N, Smith H, Stevens K, Su JY, Ward J, Whiley DM.

Clin Infect Dis. 2016 Dec 15;63(12):1591-1598. Epub 2016 Sep 28.

PMID:
27682063
16.

Real-time PCR detection of Neisseria gonorrhoeae susceptibility to penicillin.

Buckley C, Trembizki E, Donovan B, Chen M, Freeman K, Guy R, Lahra MM, Kundu RL, Regan DG, Smith HV, Whiley DM; Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRAND) Study Investigators.

J Antimicrob Chemother. 2016 Nov;71(11):3090-3095. Epub 2016 Jul 25.

PMID:
27494921
17.

Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.

Tai AS, Bell SC, Kidd TJ, Trembizki E, Buckley C, Ramsay KA, David M, Wainwright CE, Grimwood K, Whiley DM.

PLoS One. 2015 Dec 3;10(12):e0144022. doi: 10.1371/journal.pone.0144022. eCollection 2015.

18.

A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.

Buckley C, Trembizki E, Donovan B, Chen M, Freeman K, Guy R, Kundu R, Lahra MM, Regan DG, Smith H, Whiley DM; GRAND Study Investigators.

J Antimicrob Chemother. 2016 Feb;71(2):353-6. doi: 10.1093/jac/dkv366. Epub 2015 Nov 3.

PMID:
26538505
19.

Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance.

Trembizki E, Buckley C, Donovan B, Chen M, Guy R, Kaldor J, Lahra MM, Regan DG, Smith H, Ward J, Whiley DM.

J Antimicrob Chemother. 2015 Dec;70(12):3244-9. doi: 10.1093/jac/dkv274. Epub 2015 Sep 3.

PMID:
26338048
20.

Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia.

Trembizki E, Doyle C, Buckley C, Jennison A, Smith H, Bates J, Sloots T, Nissen M, Lahra MM, Whiley D.

Sex Health. 2015 Oct;12(5):439-44. doi: 10.1071/SH15009.

PMID:
26145099
21.

Multitarget PCR Assay for Direct Detection of Penicillinase-Producing Neisseria gonorrhoeae for Enhanced Surveillance of Gonococcal Antimicrobial Resistance.

Buckley C, Trembizki E, Baird RW, Chen M, Donovan B, Freeman K, Goire N, Guy R, Lahra MM, Regan D, Whiley DM.

J Clin Microbiol. 2015 Aug;53(8):2706-8. doi: 10.1128/JCM.00540-15. Epub 2015 May 20.

22.

Opportunities and pitfalls of molecular testing for detecting sexually transmitted pathogens.

Trembizki E, Costa AM, Tabrizi SN, Whiley DM, Twin J.

Pathology. 2015 Apr;47(3):219-26. doi: 10.1097/PAT.0000000000000239. Review.

PMID:
25714587
23.

Penicillinase-producing plasmid types in Neisseria gonorrhoeae clinical isolates from Australia.

Whiley D, Trembizki E, Buckley C, Freeman K, Lawrence A, Limnios A, Pearson J, Smith H, Stevens K, Lahra MM.

Antimicrob Agents Chemother. 2014 Dec;58(12):7576-8. doi: 10.1128/AAC.04120-14. Epub 2014 Sep 29.

24.

Characterization of a novel Neisseria gonorrhoeae penicillinase-producing plasmid isolated in Australia in 2012.

Trembizki E, Buckley C, Lawrence A, Lahra M, Whiley D; GRAND Study Investigators.

Antimicrob Agents Chemother. 2014 Aug;58(8):4984-5. doi: 10.1128/AAC.02993-14. Epub 2014 Jun 2. No abstract available.

25.

A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence.

Trembizki E, Doyle C, Jennison A, Smith H, Bates J, Lahra M, Whiley D; GRAND study investigators.

J Med Microbiol. 2014 Aug;63(Pt 8):1113-5. doi: 10.1099/jmm.0.074286-0. Epub 2014 May 16. No abstract available.

PMID:
24836415
26.

High-throughput informative single nucleotide polymorphism-based typing of Neisseria gonorrhoeae using the Sequenom MassARRAY iPLEX platform.

Trembizki E, Smith H, Lahra MM, Chen M, Donovan B, Fairley CK, Guy R, Kaldor J, Regan D, Ward J, Nissen MD, Sloots TP, Whiley DM.

J Antimicrob Chemother. 2014 Jun;69(6):1526-32. doi: 10.1093/jac/dkt544. Epub 2014 Jan 26.

PMID:
24468863
27.

A national quality assurance survey of Neisseria gonorrhoeae testing.

Trembizki E, Lahra M, Stevens K, Freeman K, Hogan T, Hogg G, Lawrence A, Limnios A, Pearson J, Smith H, Nissen M, Sloots T, Whiley D; GRAND study investigators.

J Med Microbiol. 2014 Jan;63(Pt 1):45-9. doi: 10.1099/jmm.0.065094-0. Epub 2013 Oct 3.

PMID:
24092762

Supplemental Content

Loading ...
Support Center